Abstract | BACKGROUND: METHODS: Data were obtained from the National Health Insurance Research Database in Taiwan. We retrospectively compared the data of patients with and without statin exposure after ICH. The outcomes of interest were recurrence of hemorrhagic stroke and mortality during a follow-up period of 10 years. RESULTS: During the 10-year follow-up period, the mortality rate was 32.73% in the statin group and 42.77% in the non- statin group. Statin therapy in patients with acute ICH with dyslipidemia can decrease mortality. CONCLUSION:
|
Authors | Cheng-Kai Lin, Po-Yuan Chen, Yu-Ying Wu, Cheng-Chun Wu, Han-Jung Chen, Cheng-Loong Liang, Yi-Che Lee, Chi-Wei Lin, Chao-Ming Hung, Hao-Kuang Wang |
Journal | Risk management and healthcare policy
(Risk Manag Healthc Policy)
Vol. 14
Pg. 177-183
( 2021)
ISSN: 1179-1594 [Print] England |
PMID | 33488130
(Publication Type: Journal Article)
|
Copyright | © 2021 Lin et al. |